Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma | Synapse
January 1, 2021
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
Key Points
Key points are not available for this paper at this time.
Abstract
For patients with intermediate-stage HCC, LEN-TACE sequential therapy may provide a deep response and favorable prognosis.